Abcellera Biologics Inc ABCL

$12.37 -0.24 (-1.90%)

Valuation

Market cap
3,866,365,000
Revenue TTM
$75,130,000
Net income TTM
$-146,410,000
PE ratio
0.00
Forward PE
—
Profit margin
-194.88%
Debt to equity
0.00

Trading

Volume
3,045,700
Avg volume
7,176,612
Day's range
$12.26 – $12.84
Shares out
306,611,000
Stochastic %K
18%
Beta
1.41
Analysts
Strong Sell
Price target
$16.82

Price

Company profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-medi...

Show more

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; AbbVie Inc.; Jazz Pharmaceuticals plc to develop T-cell engaging (TCE) multispecific antibodies; partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc.; and Vertex Pharmaceuticals Incorporated to research, develop, manufacture, and commercialize multispecific T-cell engagers (TCEs) for autoimmune diseases and other conditions. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.

Industry
Biotechnology
Sector
Healthcare
Phone
604 559 9005
Website
https://www.abcellera.com
Address
150 W 4th Avenue, Vancouver, Canada

Latest news

Stocktwits

Stocktradesmoon Oct 15, 3:47 AM
$ABCL Date to mark: ABCL635 data goes up Thursday, Oct 22, 6:15 to 7:15pm PDT in San Diego, poster P-92 at TMS 2026, per AbCellera’s Oct 8 release. Safety, PK, PD and efficacy in one session.
0 replies
Bastox Oct 15, 3:16 AM
$ABCL Time for the big girl panties
0 replies
Stocktradesmoon Oct 15, 2:16 AM
$ABCL
0 replies
Stocktradesmoon Oct 15, 2:16 AM
$ABCL
0 replies
Stocktradesmoon Oct 15, 2:15 AM
$ABCL🔥 Get in NOW!! We GOT a MAJOR CATALYST in a few days!!! After an “IMPRESSIVE & a HOME-RUN of Phase II RESULTS WE have.. Now been INVITED to PRESENT at the LARGEST 2026 TMS “THE MENOPAUSE SOCIETY” in the WORLD 🔥 STARTING NEXT TUESDAY!! 🚨Guess What, we are PRESENTING the 12 WEEK DATA 📊 for Phase II @ this CONFERENCE in front of Millions of People & Institutions and this will make itself known to the ENTIRE WORLD. 👂 🌍 If you thought 💭 that the Move for Phase II result was “BIG” your fooling yourself! This is the “BIG” move we been waiting for. When people hear ABOUT the 12 week Data 📊 and see the Results for themselves for 90 days. 😮 🤯 🔥 BOOM!! We going to SKY ROCKET $18-$23🚀! Carl CEO $ABCL in his own words said “Patient’s were CURED” YES “CURED”!! Patients went from experiencing “10 EVENTS a day to ZERO” in less than 4 weeks!! This is a “f******* “BIG”DEAL!! 🔥 They are going to be ADDING $ABCL to their portfolios and BUYING it UP!! The RESULTS are “flawless”!!! 🤯 🚀
0 replies
Targhee Oct 15, 1:23 AM
$ABCL
1 replies
Ripvip Oct 15, 12:46 AM
$ABCL this is a phenomenal product and great company. Our future problems will be so much less when women no longer have viscous mood swings and hot hot spasms flooding their bodies for years , during their 50s and 60s. Men will be so much happier not having to defend themselves against a lover who turned angry, for no reason except menopausal eruption and hate . That negative expression detailed by the body not able to handle hot flashes and partners can be overcome and gone by this new drug. Let’s get this in our medicine cabinets.
0 replies
Stocktradesmoon Oct 14, 7:55 PM
$ABCL 🔥 Get in NOW!! We GOT a MAJOR CATALYST in a few days!!! After an “IMPRESSIVE & a HOME-RUN of Phase II RESULTS WE have.. Now been INVITED to PRESENT at the LARGEST 2026 TMS “THE MENOPAUSE SOCIETY” in the WORLD 🔥 STARTING NEXT TUESDAY!! 🚨Guess What, we are PRESENTING the 12 WEEK DATA 📊 for Phase II @ this CONFERENCE in front of Millions of People & Institutions and this will make itself known to the ENTIRE WORLD. 👂 🌍 If you thought 💭 that the Move for Phase II result was “BIG” your fooling yourself! This is the “BIG” move we been waiting for. When people hear ABOUT the 12 week Data 📊 and see the Results for themselves for 90 days. 😮 🤯 🔥 BOOM!! We going to SKY ROCKET $18-$23🚀! Carl CEO $ABCL in his own words said “Patient’s were CURED” YES “CURED”!! Patients went from experiencing “10 EVENTS a day to ZERO” in less than 4 weeks!! This is a “f******* “BIG”DEAL!! 🔥 They are going to be ADDING $ABCL to their portfolios and BUYING it UP!! The RESULTS are “flawless”!!! 🤯 🚀
1 replies